Replies to post #792493 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

You are completely ignoring the Street’s view on Advent which could easily fetch a $300M market cap with some multiple built in, so now where does that leave you? Why didn’t the Street react?

[Investor082]

It won’t be even close to $1 on UK approval alone! They will need reimbursement support to get to a $1.5B market cap. Otherwise, the revenues will not exceed $10-15M annually. At those revenues, I
doubt the market will even value NWBO at where it is today given the need for ongoing dilution, how long everything has taken, and lack of clarity around FDA BLA.

The major re-rating (at $1 or thereabouts) would only come with significant non dilutive funding from big pharma. But that ain’t happening.

Any spike we get at UK approval (if there is one!) won’t last long at all. It will be another opportunity for LP’s financiers and shorts to make a ton of money again as bag holders wait for the elusive $1, which will never come! ;)

[kabunushi]

So you no longer feel like you did 3 weeks ago when you wrote the following?

There will be no questions remaining, no more bashing, no more "its doesn't work" and all the other BS we have to endure. It will have gone through on of the most extensive reviews in MHRA history. That will bring credence and legitimacy to everything NWBO has/is doing. You want a higher share-price....20-30x?

[norisknorewards]

"Massive debt"

Please show nwbo current debt, otherwise bs